Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SHEZF 上一季度的收入表现如何？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 的收入预期是多少？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 的盈利质量评分是多少？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 何时发布财报？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 的预期收益是多少？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 是否超出收益预期？
关键数据
前收盘价
$0.4696
开盘价
$0.7206
当日区间
$0.4696 - $0.7206
52周范围
$0.4696 - $0.7206
交易量
25
平均成交量
0
每股收益（TTM）
-0.02
股息收益率
--
市值
$103.3M
什么是 SHENZHEN HEPALINK PHARMACEUTICA？
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.
